Co-administration of MDR1 and BCRP or EGFR/PI3K inhibitors overcomes lenvatinib resistance in hepatocellular carcinomaDawei Sun, Jiahong Dong|Frontiers in Oncology|2022Cited by 43
Programmed death ligand-1, tumor infiltrating lymphocytes and HLA expression in Chinese extrahepatic cholangiocarcinoma patients: Possible immunotherapy implicationsFei Yu, Jiahong Dong|BioScience Trends|2019Cited by 27
Lapatinib Suppresses HER2-Overexpressed Cholangiocarcinoma and Overcomes ABCB1– Mediated Gemcitabine ChemoresistanceZhiqing Bai, Jiahong Dong|Frontiers in Oncology|2022Cited by 19
Prostaglandin E2-driven dedifferentiation of Schwann cells leads to perineural invasion in pancreatic ductal adenocarcinomaLing Wang, Jiahong Dong|Signal Transduction and Targeted Therapy|2026Cited by 0